A satellite symposium co organised by the Global Vaccine Enterprise, European Commission, ANRS, AVAC, IAVI, Bill and Melinda Gates Foundation, NIH-NIAID
A safe and effective HIV Vaccine remains our best chance at ending the epidemic. How close are we to developing an HIV Vaccine? What are the latest developments in basic and clinical science? How are these new discoveries informing vaccine design and testing? What might future clinical trials look like in the midst of other new HIV prevention research results?